Gregory S. Cameron

5.2k citations
40 papers · 4.1k · 3 hit papers · h-index 25

Impact in

  • Dermatology top 0.2%
    • Dermatology and Skin Diseases
    • Skin Protection and Aging
  • Immunology top 0.5%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Psoriasis: Treatment and Pathogenesis 12
    • Polyamine Metabolism and Applications 6
    • Peroxisome Proliferator-Activated Receptors 3
    • Genomics, phytochemicals, and oxidative stress 2

Gregory S. Cameron

40 papers receiving 4.1k citations

Gregory S. Cameron's Hit Papers

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis 2016 · 666 citations
6660+4+9Years since publication200400600

Peers

Gregory S. Cameron
Comparison fields: 5 of 109
  • Dermatology 1.2k
  • Immunology 2.6k
  • Endocrine and Autonomic Systems 272
  • Rheumatology 449
  • Physiology 576
Replace Reinhart Speeckaert with:
Reinhart Speeckaert Belgium
M.W. Greaves United Kingdom
Anna Campanati Italy
Soraya Taleb France
G Michaëlsson Sweden
Andrea Szegedi Hungary
Jelena Mann United Kingdom
Huihua Li United States
Antoon J. M. van Oosterhout Netherlands
Shih‐Chi Su Taiwan
Gregory S. Cameron relative to Reinhart Speeckaert Belgium Reinhart Speeckaert's profile →
Citations per field
00.5×10×14.3×
Reinhart Speeckaert · 1×
Citations per year

Countries citing papers authored by Gregory S. Cameron

Since Specialization
Citations

This map shows the geographic impact of Gregory S. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Cameron more than expected).

Fields of papers citing papers by Gregory S. Cameron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Cameron. The network helps show where Gregory S. Cameron may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory S. Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory S. Cameron Line = papers co-authored together Gregory S. Cameron links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Hit paper breakdown →
2012746
2
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Hit paper breakdown →
2016666
3
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Hit paper breakdown →
2015664
4 2008367
5 2012304
6 2014175
7 2016158
8 1996118
9 201487
10
Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction.
198878
11 201777
12 199572
13 201567
14 199965
15
The differentiation capacity of Clara cells isolated from the lungs of rabbits.
198746
16 198841
17 201739
18
Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
198939
19 201335
20 200030

About Gregory S. Cameron

Gregory S. Cameron is a scholar working on Immunology, Molecular Biology, Dermatology, Pharmacology and Biochemistry, having authored 40 papers that have together received 4.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (12 papers), Polyamine Metabolism and Applications (6 papers), Inflammatory mediators and NSAID effects (5 papers), Skin Protection and Aging (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Estrogen and related hormone effects (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Dermatology (1.2k citations), Immunology (2.6k citations), Endocrine and Autonomic Systems (272 citations), Rheumatology (449 citations) and Physiology (576 citations). Gregory S. Cameron has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Craig L. Leonardi, Subhashis Banerjee, Daniel Braun, Emily Edson‐Heredia, Claus Zachariae, Daniel Braun, J. Erickson, Robert Matheson, Linda Li and Olawale Osuntokun. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, New England Journal of Medicine, The Journal of Dermatology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact